Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Discordant Diagnostic Terminology and Pathologic Grading of Primary Appendiceal Mucinous Neoplasms Reviewed at a High-Volume Center.

Choudry HA, Pai RK, Parimi A, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Bartlett DL.

Ann Surg Oncol. 2019 May 20. doi: 10.1245/s10434-019-07447-z. [Epub ahead of print]

PMID:
31111354
2.

Correction to: Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies.

Choudry MHA, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2019 Apr 11. doi: 10.1245/s10434-019-07349-0. [Epub ahead of print]

PMID:
30980195
3.

Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.

Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, Das R, Sarkaria S, Ayasso MS, Wald AI, Monaco SE, Nalesnik M, Ohori NP, Geller D, Tsung A, Zureikat AH, Zeh H, Marsh JW, Hogg M, Lee K, Bartlett DL, Pingpank JF, Humar A, Bahary N, Dasyam AK, Brand R, Fasanella KE, McGrath K, Slivka A.

Gut. 2019 Apr 10. pii: gutjnl-2018-317817. doi: 10.1136/gutjnl-2018-317817. [Epub ahead of print]

4.

Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants.

LaFramboise WA, Pai RK, Petrosko P, Belsky MA, Dhir A, Howard PG, Becich MJ, Holtzman MP, Ahrendt SA, Pingpank JF, Zeh HJ, Dhir R, Bartlett DL, Choudry HA.

Mod Pathol. 2019 Apr 8. doi: 10.1038/s41379-019-0256-2. [Epub ahead of print]

PMID:
30962504
5.

Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.

Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2019 May;26(5):1445-1453. doi: 10.1245/s10434-019-07218-w. Epub 2019 Mar 1.

PMID:
30825033
6.

A cautionary note on the selectivity of oncolytic poxviruses.

Tang B, Guo ZS, Bartlett DL, Liu J, McFadden G, Shisler JL, Roy EJ.

Oncolytic Virother. 2019 Feb 11;8:3-8. doi: 10.2147/OV.S189832. eCollection 2019.

7.

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.

Guo ZS, Lu B, Guo Z, Giehl E, Feist M, Dai E, Liu W, Storkus WJ, He Y, Liu Z, Bartlett DL.

J Immunother Cancer. 2019 Jan 9;7(1):6. doi: 10.1186/s40425-018-0495-7. Review.

8.

Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.

Beane JD, Wilson GC, Sutton JM, Shuai Y, Ramalingam L, Jones HL, Pingpank JF 2nd, Holtzman MP, Zureikat AJ, Ahrendt SA, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2019 May;26(5):1429-1436. doi: 10.1245/s10434-018-07091-z. Epub 2019 Jan 8.

PMID:
30623341
9.

Correction to: Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship.

Knab LM, Zenati MS, Khodakov A, Rice M, Al-Abbas A, Bartlett DL, Zureikat AH, Zeh HJ, Hogg ME.

Ann Surg Oncol. 2018 Dec 12. doi: 10.1245/s10434-018-07106-9. [Epub ahead of print]

PMID:
30542838
10.

Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2.

Liu Z, Ge Y, Wang H, Ma C, Feist M, Ju S, Guo ZS, Bartlett DL.

Nat Commun. 2018 Nov 8;9(1):4682. doi: 10.1038/s41467-018-06954-z.

11.

Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies.

Choudry MHA, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2018 Dec;25(13):3950-3959. doi: 10.1245/s10434-018-6823-9. Epub 2018 Oct 9. Erratum in: Ann Surg Oncol. 2019 Apr 11;:.

PMID:
30302637
12.

Gasless Transaxillary Endoscopic Thyroidectomy with Robotic Assistance: A High-Volume Experience in North America.

Stang MT, Yip L, Wharry L, Bartlett DL, McCoy KL, Carty SE.

Thyroid. 2018 Dec;28(12):1655-1661. doi: 10.1089/thy.2018.0404. Epub 2018 Oct 16.

PMID:
30235982
13.

Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.

Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ.

J Cell Biochem. 2019 Jan;120(1):928-939. doi: 10.1002/jcb.27456. Epub 2018 Aug 30.

PMID:
30160785
14.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G; PSOGI and BIG RENAPE working groups.

Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. doi: 10.1016/j.ejso.2018.04.023. Epub 2018 Jun 19.

PMID:
30131104
15.

Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship.

Mark Knab L, Zenati MS, Khodakov A, Rice M, Al-Abbas A, Bartlett DL, Zureikat AH, Zeh HJ, Hogg ME.

Ann Surg Oncol. 2018 Nov;25(12):3445-3452. doi: 10.1245/s10434-018-6686-0. Epub 2018 Aug 2. Erratum in: Ann Surg Oncol. 2018 Dec 12;:.

PMID:
30073601
16.

Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade.

Kowalsky SJ, Liu Z, Feist M, Berkey SE, Ma C, Ravindranathan R, Dai E, Roy EJ, Guo ZS, Bartlett DL.

Mol Ther. 2018 Oct 3;26(10):2476-2486. doi: 10.1016/j.ymthe.2018.07.013. Epub 2018 Jul 17.

17.

PARK7 modulates autophagic proteolysis through binding to the N-terminally arginylated form of the molecular chaperone HSPA5.

Lee DH, Kim D, Kim ST, Jeong S, Kim JL, Shim SM, Heo AJ, Song X, Guo ZS, Bartlett DL, Oh SC, Lee J, Saito Y, Kim BY, Kwon YT, Lee YJ.

Autophagy. 2018;14(11):1870-1885. doi: 10.1080/15548627.2018.1491212. Epub 2018 Jul 23.

PMID:
29976090
18.

Current Management and Future Opportunities for Peritoneal Metastases.

Bartlett DL.

Ann Surg Oncol. 2018 Aug;25(8):2132-2134. doi: 10.1245/s10434-018-6520-8. Epub 2018 Jun 8. No abstract available.

PMID:
29948419
19.

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study.

Mehta S, Schwarz L, Spiliotis J, Hsieh MC, Akaishi EH, Goere D, Sugarbaker PH, Baratti D, Quenet F, Bartlett DL, Villeneuve L, Kepenekian V; PSOGI and BIG-RENAPE Working Groups.

Eur J Surg Oncol. 2018 Nov;44(11):1786-1792. doi: 10.1016/j.ejso.2018.05.021. Epub 2018 May 28.

PMID:
29885982
20.

Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.

Boone BA, Perkins S, Bandi R, Santos E, McCluskey K, Bartlett DL, Pingpank JF.

J Surg Oncol. 2018 Apr;117(5):940-946. doi: 10.1002/jso.24984.

21.

Correction: Molecular crosstalk between ferroptosis and apoptosis: Emerging role of ER stress-induced p53-independent PUMA expression.

Hong SH, Lee DH, Lee YS, Jo MJ, Jeong YA, Kwon WT, Choudry HA, Bartlett DL, Lee YJ.

Oncotarget. 2018 May 15;9(37):24869. doi: 10.18632/oncotarget.25365. eCollection 2018 May 15.

22.

Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment.

Theodoraki MN, Yerneni S, Sarkar SN, Orr B, Muthuswamy R, Voyten J, Modugno F, Jiang W, Grimm M, Basse PH, Bartlett DL, Edwards RP, Kalinski P.

Cancer Res. 2018 Aug 1;78(15):4292-4302. doi: 10.1158/0008-5472.CAN-17-3985. Epub 2018 May 31.

PMID:
29853604
23.

Together We Make a Difference.

Turaga KK, Clark Gamblin T, Richard Alexander H, Edwards R, Bartlett DL.

Ann Surg Oncol. 2018 Jul;25(7):1794-1796. doi: 10.1245/s10434-018-6338-4. Epub 2018 May 15. No abstract available.

PMID:
29766390
24.

Crosstalk Between Apoptosis and Autophagy Is Regulated by the Arginylated BiP/Beclin-1/p62 Complex.

Song X, Lee DH, Dilly AK, Lee YS, Choudry HA, Kwon YT, Bartlett DL, Lee YJ.

Mol Cancer Res. 2018 Jul;16(7):1077-1091. doi: 10.1158/1541-7786.MCR-17-0685. Epub 2018 Apr 18.

PMID:
29669822
25.

Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.

Mercier F, Bakrin N, Bartlett DL, Goere D, Quenet F, Dumont F, Heyd B, Abboud K, Marolho C, Villeneuve L, Glehen O; PSOGI Working Group; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Jun;25(6):1668-1675. doi: 10.1245/s10434-018-6464-z. Epub 2018 Apr 10.

PMID:
29637438
26.

Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis.

Lee YS, Lee DH, Choudry HA, Bartlett DL, Lee YJ.

Mol Cancer Res. 2018 Jul;16(7):1073-1076. doi: 10.1158/1541-7786.MCR-18-0055. Epub 2018 Mar 28. Review.

PMID:
29592897
27.

Fitbit step counts during inpatient recovery from cancer surgery as a predictor of readmission.

Low CA, Bovbjerg DH, Ahrendt S, Choudry MH, Holtzman M, Jones HL, Pingpank JF Jr, Ramalingam L, Zeh HJ 3rd, Zureikat AH, Bartlett DL.

Ann Behav Med. 2018 Jan 5;52(1):88-92. doi: 10.1093/abm/kax022.

28.

Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression.

Hong SH, Lee DH, Lee YS, Jo MJ, Jeong YA, Kwon WT, Choudry HA, Bartlett DL, Lee YJ.

Oncotarget. 2017 Dec 8;8(70):115164-115178. doi: 10.18632/oncotarget.23046. eCollection 2017 Dec 29. Erratum in: Oncotarget. 2018 May 15;9(37):24869.

29.

Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents.

Obermajer N, Urban J, Wieckowski E, Muthuswamy R, Ravindranathan R, Bartlett DL, Kalinski P.

Nat Protoc. 2018 Feb;13(2):335-357. doi: 10.1038/nprot.2017.130. Epub 2018 Jan 18.

PMID:
29345636
30.

Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei.

Dilly AK, Honick BD, Lee YJ, Guo ZS, Zeh HJ, Bartlett DL, Choudry HA.

Oncotarget. 2017 Nov 6;8(63):106888-106900. doi: 10.18632/oncotarget.22455. eCollection 2017 Dec 5.

31.

Oncolytic Virotherapy and the Tumor Microenvironment.

Berkey SE, Thorne SH, Bartlett DL.

Adv Exp Med Biol. 2017;1036:157-172. doi: 10.1007/978-3-319-67577-0_11. Review.

PMID:
29275471
32.

JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.

Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng D, Wang P, Ma X, Kroemer G, Bartlett DL, Billiar TR, Lotze MT, Zeh HJ, Kang R, Tang D.

Gastroenterology. 2018 Apr;154(5):1480-1493. doi: 10.1053/j.gastro.2017.12.004. Epub 2017 Dec 14.

33.

Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.

Mercier F, Passot G, Villeneuve L, Levine EA, Yonemura Y, Goéré D, Sugarbaker PH, Marolho C, Bartlett DL, Glehen O; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Apr;25(4):1094-1100. doi: 10.1245/s10434-017-6299-z. Epub 2017 Dec 13.

PMID:
29238881
34.

Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).

Dhir M, Zenati MS, Jones HL, Bartlett DL, Choudry MHA, Pingpank JF, Holtzman MP, Bahary N, Hogg ME, Zeh HJ 3rd, Geller DA, Wallis Marsh J, Tsung A, Zureikat AH.

Ann Surg Oncol. 2018 Feb;25(2):550-557. doi: 10.1245/s10434-017-6265-9. Epub 2017 Nov 27.

PMID:
29181682
35.

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei.

Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2018 Jan;25(1):76-82. doi: 10.1245/s10434-017-6214-7. Epub 2017 Nov 6.

PMID:
29110275
36.

Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.

Guo ZS, Liu Z, Sathaiah M, Wang J, Ravindranathan R, Kim E, Huang S, Kenniston TW, Bell JC, Zeh HJ 3rd, Butterfield LH, Gambotto A, Bartlett DL.

Mol Ther Methods Clin Dev. 2017 Sep 30;7:112-122. doi: 10.1016/j.omtm.2017.09.007. eCollection 2017 Dec 15.

37.

Safety and efficacy of combined resection of colorectal peritoneal and liver metastases.

Downs-Canner S, Shuai Y, Ramalingam L, Pingpank JF, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA.

J Surg Res. 2017 Nov;219:194-201. doi: 10.1016/j.jss.2017.05.126. Epub 2017 Jun 29.

38.

Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies.

Wright GP, Perkins S, Jones H, Zureikat AH, Marsh JW, Holtzman MP, Zeh HJ 3rd, Bartlett DL, Pingpank JF Jr.

Ann Surg Oncol. 2018 Jan;25(1):83-90. doi: 10.1245/s10434-017-6110-1. Epub 2017 Oct 23.

PMID:
29063296
39.

Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion.

Pakraftar S, Ramalingam L, Shuai Y, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2017 Dec;24(13):3811-3817. doi: 10.1245/s10434-017-6114-x. Epub 2017 Oct 10.

PMID:
29019111
40.

Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.

Singhi AD, McGrath K, Brand RE, Khalid A, Zeh HJ, Chennat JS, Fasanella KE, Papachristou GI, Slivka A, Bartlett DL, Dasyam AK, Hogg M, Lee KK, Marsh JW, Monaco SE, Ohori NP, Pingpank JF, Tsung A, Zureikat AH, Wald AI, Nikiforova MN.

Gut. 2018 Dec;67(12):2131-2141. doi: 10.1136/gutjnl-2016-313586. Epub 2017 Sep 28.

41.

Factors associated with prolonged hospitalization in patients undergoing pancreatoduodenectomy.

Radomski M, Zenati M, Novak S, Tam V, Steve J, Bartlett DL, Zureikat AH, Zeh HJ 3rd, Hogg ME.

Am J Surg. 2018 Apr;215(4):636-642. doi: 10.1016/j.amjsurg.2017.06.040. Epub 2017 Sep 18.

PMID:
28958654
42.

Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.

Dhir M, Li W, Hogg ME, Bartlett DL, Carty SE, McCoy KL, Challinor SM, Yip L.

Ann Surg Oncol. 2017 Nov;24(12):3624-3630. doi: 10.1245/s10434-017-6074-1. Epub 2017 Sep 7.

PMID:
28884434
43.

Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer.

Guo ZS, Bartlett DL.

Biomedicines. 2017 Aug 24;5(3). pii: E52. doi: 10.3390/biomedicines5030052.

44.

Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.

Magge D, Ramalingam L, Shuai Y, Edwards RP, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA.

J Surg Oncol. 2017 Sep;116(3):320-328. doi: 10.1002/jso.24666. Epub 2017 Jun 19.

45.

Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives.

Guo ZS, Liu Z, Kowalsky S, Feist M, Kalinski P, Lu B, Storkus WJ, Bartlett DL.

Front Immunol. 2017 May 15;8:555. doi: 10.3389/fimmu.2017.00555. eCollection 2017. Review.

46.

Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI).

Goéré D, Passot G, Gelli M, Levine EA, Bartlett DL, Sugarbaker PH, Glehen O.

Int J Hyperthermia. 2017 Aug;33(5):520-527. doi: 10.1080/02656736.2017.1301576.

PMID:
28540827
47.

Radiation-Induced Glandular Malignant Peripheral Nerve Sheath Tumor.

John I, Bartlett DL, Rao UNM.

Int J Surg Pathol. 2017 Oct;25(7):635-639. doi: 10.1177/1066896917710718. Epub 2017 May 22.

PMID:
28530162
48.

Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.

Kang R, Xie Y, Zhang Q, Hou W, Jiang Q, Zhu S, Liu J, Zeng D, Wang H, Bartlett DL, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D.

Cell Res. 2017 Jul;27(7):916-932. doi: 10.1038/cr.2017.51. Epub 2017 Apr 4.

49.

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy.

Liu Z, Ravindranathan R, Kalinski P, Guo ZS, Bartlett DL.

Nat Commun. 2017 Mar 27;8:14754. doi: 10.1038/ncomms14754.

50.

Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells.

Downs-Canner S, Berkey S, Delgoffe GM, Edwards RP, Curiel T, Odunsi K, Bartlett DL, Obermajer N.

Nat Commun. 2017 Mar 14;8:14649. doi: 10.1038/ncomms14649.

Supplemental Content

Loading ...
Support Center